Thrombopoietin participates in platelet activation in COVID-19 patients

Thrombopoietin participates in platelet activation in COVID-19 patients

Summary: Background: The pathogenesis of coronavirus disease 2019 (COVID-19) is characterized by enhanced platelet activation and diffuse hemostatic alterations, which may contribute to immunothrombosis/thromboinflammation and subsequent development of target-organ damage.Thrombopoietin (THPO), a g...

Full description

Bibliographic Details
Main Authors: Enrico Lupia, Marialessia Capuano, Barbara Vizio, Martina Schiavello, Ornella Bosco, Maria Gelardi, Edoardo Favale, Emanuele Pivetta, Fulvio Morello, Shahid Husain, Shaf Keshavjee, Lorenzo Del Sorbo, Giuseppe Montrucchio
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:EBioMedicine
Subjects:
COVID-19
Thrombopoietin
Interleukin-6
Platelet activation
Biomarker
Thromboinflammation
Online Access:http://www.sciencedirect.com/science/article/pii/S235239642200487X

Internet

http://www.sciencedirect.com/science/article/pii/S235239642200487X

Similar Items